Multiple Sclerosis and Related Disorders

Retinal structure and function correlation in MS 2:21
Retinal structure and function correlation in MS
Steven Galetta • 15 Apr 2021
Measuring the improvement of multiple sclerosis patients over time 1:56
Measuring the improvement of multiple sclerosis patients over time
Maria Pia Sormani • 6 Apr 2021
Research towards personalized treatment in multiple sclerosis 1:37
Research towards personalized treatment in multiple sclerosis
Maria Pia Sormani • 6 Apr 2021
MOG antibody seropositivity in a multi-ethnic population 3:21
MOG antibody seropositivity in a multi-ethnic population
Anthony Traboulsee • 9 Apr 2021
The Italian MS Society collaborative project on COVID-19 data collection 2:24
The Italian MS Society collaborative project on COVID-19 data collection
Maria Pia Sormani • 6 Apr 2021
Bone marrow-derived stem cells to treat stroke, MS and chronic TBI 2:25
Bone marrow-derived stem cells to treat stroke, MS and chronic TBI
Sean Savitz • 13 Apr 2021
Satralizumab in patients with NMOSD and concomitant autoimmune diseases 1:49
Satralizumab in patients with NMOSD and concomitant autoimmune diseases
Anthony Traboulsee • 9 Apr 2021
Barriers to access of MS care services for LATAM patients 3:26
Barriers to access of MS care services for LATAM patients
Jorge Correale • 5 Mar 2021
Improving recognition of cognitive-predominant MS 1:54
Improving recognition of cognitive-predominant MS
Claire Riley • 26 Feb 2021
Moving towards precision medicine in MS with sNfL 4:21
Moving towards precision medicine in MS with sNfL
Mark Freedman • 3 Mar 2021
Constrained social networks are associated with worse physical functioning in MS 1:33
Constrained social networks are associated with worse physical functioning in MS
Claire Riley • 26 Feb 2021
Is long-term teriflunomide treatment safe in MS? 2:13
Is long-term teriflunomide treatment safe in MS?
Mark Freedman • 3 Mar 2021
Safely switching from natalizumab to ocrelizumab in patients with MS at risk of PML 2:14
Safely switching from natalizumab to ocrelizumab in patients with MS at risk of PML
Claire Riley • 26 Feb 2021
Immunomodulatory effects of vitamin D in MS 3:13
Immunomodulatory effects of vitamin D in MS
Jorge Correale • 5 Mar 2021
Assessing cognitive fatigability in MS 2:47
Assessing cognitive fatigability in MS
Mark Freedman • 3 Mar 2021
Moving forward in progressive MS 0:49
Moving forward in progressive MS
Claire Riley • 26 Feb 2021
The content of VJNeurology is intended for healthcare professionals